Log in to save to my catalogue

Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis

Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7529405

Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis

About this item

Full title

Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis

Publisher

England: Elsevier Ltd

Journal title

The Lancet (British edition), 2020-10, Vol.396 (10256), p.968-976

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Angiotensin-converting enzyme 2 (ACE2) is an endogenous counter-regulator of the renin–angiotensin hormonal cascade. We assessed whether plasma ACE2 concentrations were associated with greater risk of death or cardiovascular disease events.
We used data from the Prospective Urban Rural Epidemiology (PURE) prospective study to conduct a case-coho...

Alternative Titles

Full title

Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7529405

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7529405

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(20)31964-4

How to access this item